You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

ustekinumab

Showing 26 - 50 of 92
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Symptom Improvement of Ulcerative Colitis AfterInduction Dose of

Active, not recruiting
  • Ulcerative Colitis
  • Ustekinumab
  • Bunkyo-ku, Japan
  • +23 more
Aug 17, 2022

Psoriasis Trial (risankizumab, ustekinumab, for risankizumab)

Completed
Has Results
  • Psoriasis
  • (no location specified)
Jul 28, 2021

Psoriasis Trial (risankizumab, for risankizumab, ustekinumab)

Completed
Has Results
  • Psoriasis
  • (no location specified)
Jul 28, 2021

Combined Microbiota and Metabolic Signature in Ulcerative

Not yet recruiting
  • Ulcerative Colitis
  • (no location specified)
Jan 26, 2023

Crohn Disease Trial in China (Ustekinumab)

Recruiting
  • Crohn Disease
  • Ustekinumab
  • Beijing, China
  • +28 more
Aug 17, 2022

Takayasu Arteritis Trial in Japan (Ustekinumab, Placebo, Glucorticoid Taper Regimen)

Recruiting
  • Takayasu Arteritis
  • Ustekinumab
  • +2 more
  • Bunkyo-Ku, Japan
  • +28 more
Aug 16, 2022

Psoriasis Trial in Barcelona, Granada, Pontevedra (Brodalumab, Ustekinumab, Placebo)

Recruiting
  • Psoriasis
  • Brussels, Bruxelles-Capitale, Belgium
  • +21 more
Jan 27, 2023

Crohn Disease Trial in Worldwide (BI 706321, ustekinumab, Placebo)

Recruiting
  • Crohn Disease
  • BI 706321
  • +2 more
  • Northridge, California
  • +30 more
Aug 2, 2022

Uveitis Trial run by the NEI (Ustekinumab)

Completed
Has Results
  • Uveitis
  • Ustekinumab
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Mar 4, 2021

Molecular Signatures in Inflammatory Skin Disease

Recruiting
  • Atopic Dermatitis
  • Psoriasis
  • Ustekinumab
  • +9 more
  • Kiel, Germany
    Department of Dermatology, University Hospital Schleswig Holstei
Jul 16, 2022

Pediatric Participants Aged 6 Years and Older With Moderate to

Recruiting
  • Psoriasis
  • Ustekinumab
  • Graz, Austria
  • +33 more
Aug 17, 2022

Skin Inflammation, Allergic Contact Dermatitis Trial in Worcester (drug, other, device)

Recruiting
  • Skin Inflammation
  • Allergic Contact Dermatitis
  • Squaric Acid Dibutyl Ester
  • +12 more
  • Worcester, Massachusetts
    University of Massachusetts Chan Medical School
Sep 6, 2022

A Multicentered Prospective Cohort Study of Chinese IBD Patients

Enrolling by invitation
  • Ulcerative Colitis
  • Crohn Disease
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
May 17, 2022

Arthritis, Juvenile Trial in Worldwide (Ustekinumab, Guselkumab)

Recruiting
  • Arthritis, Juvenile
  • Birmingham, Alabama
  • +50 more
Jan 31, 2023

Psoriasis Trial in Athens (etanercept, ustekinumab, cyclosporine)

Recruiting
  • Psoriasis
  • Athens, Greece
    Attikon Hospital
Mar 28, 2022

Crohn Disease Trial in Worldwide (Ustekinumab, Placebo)

Recruiting
  • Crohn Disease
  • Ustekinumab
  • Placebo
  • Wilmington, Delaware
  • +57 more
Mar 30, 2022

Psoriatic Arthritis, Withdrawal, Reduction Trial in Erlangen (Prednisolone, Sulfasalazine, Leflunomide)

Recruiting
  • Psoriatic Arthritis
  • +2 more
  • Erlangen, Bavaria, Germany
    Universitätsklinikum Erlangen
Nov 10, 2022

Crohn Disease Trial in Pierre-Bénite (Anti-TNF Drug, Ustekinumab)

Not yet recruiting
  • Crohn Disease
  • Anti-TNF Drug
  • Ustekinumab
  • Pierre-Bénite, France
    Centre Hospitalier Lyon Sud
Jul 26, 2021

Pouchitis Trial in Leuven, Brussels, Liège (Ustekinumab)

Recruiting
  • Pouchitis
  • Ustekinumab
  • Leuven, Vlaanderen, Belgium
  • +2 more
Apr 27, 2021

Psoriasis Trial in Worldwide (Ustekinumab, ABP 654)

Active, not recruiting
  • Psoriasis
  • Ustekinumab
  • ABP 654
  • Hot Springs, Arkansas
  • +87 more
Nov 4, 2022

Crohn Disease Trial in Brazil (Ustekinumab)

No longer available
  • Crohn Disease
  • Ustekinumab
  • Curitiba, Brazil
  • +7 more
Nov 12, 2020

Crohn's Disease Participants Treated With Stelara (Ustekinumab)

Completed
  • Crohn Disease
  • Ustekinumab
  • Ansan-si, Korea, Republic of
  • +42 more
Mar 30, 2022

Giant Cell Arteritis, Temporal Arteritis, Horton's Disease Trial in Boston (Ustekinumab, Prednisone)

Terminated
Has Results
  • Giant Cell Arteritis
  • +2 more
  • Boston, Massachusetts
    Massachusetts General Hospital
Jun 10, 2020

Crohn Disease Trial in Evansville (JNJ-64304500, Placebo, Adalimumab)

Withdrawn
  • Crohn Disease
  • Evansville, Indiana
    Medisphere Medical Research Center, Llc
Aug 30, 2021

Psoriasis, Pregnancy, Psoriatic Arthritis Trial in La Jolla (Ustekinumab, Guselkumab)

Recruiting
  • Psoriasis
  • +3 more
  • La Jolla, California
    University of California, San Diego
Apr 1, 2021